Christopher David - Jan 16, 2024 Form 4 Insider Report for Novo Integrated Sciences, Inc. (NOVO)

Role: Chief Operating Officer, Director
Signature: /s/ Christopher David
Stock symbol: NOVO
Transactions as of: Jan 16, 2024
Transactions value $: $0
Form type: 4
Date filed: 9/12/2024, 06:05 AM
Previous filing: Jun 2, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	NOVO	Class A Common Stock						8.2K	Jan 16, 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NOVO	Stock Option (right to buy)	Award	$0	+200K		$0.00	200K	Jan 16, 2024	Common Stock	200K	$0.78	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the grant, by the issuer's Board of Directors, of an option to purchase 200,000 shares of the issuer's common stock at an exercise price of $0.78 per share. The option was fully vested and exercisable on the date of grant and is exercisable until January 16, 2030.